Formaldehyde induces toxicity in mouse bone marrow and hematopoietic stem/progenitor cells and enhances benzene-induced adverse effects

被引:0
作者
Chenxi Wei
Huaxiao Wen
Langyue Yuan
Cliona M. McHale
Hui Li
Kun Wang
Junlin Yuan
Xu Yang
Luoping Zhang
机构
[1] Central China Normal University,Hubei Key Laboratory of Genetic Regulation and Integrative Biology, College of Life Sciences
[2] University of California,Division of Environmental Health Sciences, School of Public Health
[3] Hunan Normal University,Key Laboratory of Ecological Safety Monitoring and Evaluation, College of Life Sciences
[4] New York University,Division of Biostatistics, Department of Population Health, School of Medicine
来源
Archives of Toxicology | 2017年 / 91卷
关键词
Formaldehyde; Benzene; Hematotoxicity; Bone marrow; Myeloid progenitor;
D O I
暂无
中图分类号
学科分类号
摘要
Formaldehyde (FA) is a human leukemogen and is hematotoxic in human and mouse. The biological plausibility of FA-induced leukemia is controversial because few studies have reported FA-induced bone marrow (BM) toxicity, and none have reported BM stem/progenitor cell toxicity. We sought to comprehensively examine FA hematoxicity in vivo in mouse peripheral blood, BM, spleen and myeloid progenitors. We included the leukemogen and BM toxicant, benzene (BZ), as a positive control, separately and together with FA as co-exposure occurs frequently. We exposed BALB/c mice to 3 mg/m3 FA in air for 2 weeks, mimicking occupational exposure, then measured complete blood counts, nucleated BM cell count, and myeloid progenitor colony formation. We also investigated potential mechanisms of FA toxicity, including reactive oxygen species (ROS) generation, apoptosis, and hematopoietic growth factor and receptor levels. FA exposure significantly reduced nucleated BM cells and BM-derived colony-forming unit-granulocyte–macrophage (CFU-GM) and burst-forming unit-erythroid (BFU-E); down-regulated GM-CSFRα and EPOR expression; increased ROS in nucleated BM, spleen and CFU-GM cells; and increased apoptosis in nucleated spleen and CFU-GM cells. FA and BZ each similarly altered BM mature cells and stem/progenitor counts, BM and CFU-GM ROS, and apoptosis in spleen and CFU-GM but had differential effects on other end points. Co-exposure was more potent for several end points. Thus, FA is toxic to the mouse hematopoietic system, including BM stem/progenitor cells, and it enhances BZ-induced toxic effects. Our findings suggest that FA may induce BM toxicity by affecting myeloid progenitor growth and survival through oxidative damage and reduced expression levels of GM-CSFRα and EPOR.
引用
收藏
页码:921 / 933
页数:12
相关论文
共 197 条
[1]  
Battisti V(2008)Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients Clin Biochem 41 511-518
[2]  
Maders LD(1978)Characterization and quantification of the peroxidase in human monocytes Biochim Biophys Acta 525 37-44
[3]  
Bagatini MD(1997)Increased apoptotic cells in bone marrow biopsies from patients with aplastic anaemia Br J Haematol 98 18-20
[4]  
Bos A(1987)Further studies of the metabolic incorporation and covalent binding of inhaled [3H]- and [14C]formaldehyde in Fischer-344 rats: effects of glutathione depletion Toxicol Appl Pharmacol 89 105-121
[5]  
Wever R(1984)Differentiation between metabolic incorporation and covalent binding in the labeling of macromolecules in the rat nasal mucosa and bone marrow by inhaled [14C]- and [3H]formaldehyde Toxicol Appl Pharmacol 76 26-44
[6]  
Roos D(2010)Reactive oxygen species, cellular redox systems, and apoptosis Free Radic Biol Med 48 749-762
[7]  
Callera F(2006)Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology Eur Respir J 27 441-445
[8]  
Falcão RP(2013)Dosimetry of N(6)-formyllysine adducts following [(1)(3)C(2)H(2)]-formaldehyde exposures in rats Chem Res Toxicol 26 1421-1423
[9]  
Casanova M(2009)Erythropoietin and erythropoiesis Exp Hematol 37 1007-1015
[10]  
Heck HDA(2013)Prenatal exposure to traffic-related air pollution and risk of early childhood cancers Am J Epidemiol 178 1233-1239